Respiratory Paediatrics
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Children aged 5 to 17 years • Clinically diagnosed with allergic asthma associated with sensitization to one or more aeroallergens • Classified as partially controlled or uncontrolled asthma according to GINA guidelines • Residing in the same geographical area (Tlemcen Department) with consistent dietary habits • Eutrophic (normal nutritional status) • On standard background asthma therapy with good therapeutic adherence and regular follow-ups • Parental/guardian informed consent obtained
Exclusion criteria
Exclusion criteria: • Presence of co-morbidities (obesity, active infections within 15 days before enrollment, autoimmune diseases, cancer, or other chronic inflammatory diseases) • Active smoking • Antibiotic treatment within the past month • Non-allergic asthma • Failure to comply with the study protocol or loss to follow-up during the study • Need for antibiotic therapy during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exhaled Breath Condensate Nitric Oxide (EBCNO) level, as a biomarker of airway inflammation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Th1/Th2 cytokine balance. | — |
Countries
Algeria
Contacts
Neonatal Department of Specialized Maternal and Child Hospital of Tlemcen